B. Riley Securities analyst Matt Howlett maintains Great Ajax (NYSE:AJX) with a Buy and lowers the price target from $14 to $12.
Cresco Lab’s 1Q Results After Conference Call, Analyst Opines
The Analyst
Following Cresco Labs’ (OTC: CRLBF) (CSE:CL) conference call, Pablo Zuanic, from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.